How This Evidence Evolved
Breast Reconstruction Timing
Evolution of reconstruction timing, technique, and integration with oncologic care
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
Provision and practice of implant-based reconstruction: 81 units in 79 hospitals (patient outcomes not evaluated)
Time to adjuvant chemotherapy: four studies reported delays averaging 6.6-16.8 days after immediate reconstruction; seven reported no significant difference
Follow-up studies, subgroup analyses, and real-world validation
Complications within 3 months: implant loss 9% (95% CI 8-10), readmission 18% (16-20), return to theatre 18% (16-20), treated infection 25% (23-27)
Aesthetic symmetry and regional volume discrepancy at 6 months (effect estimates not stated in abstract)
Animation deformity: prepectoral vs subpectoral OR 0.02 (95% CI 0.00-0.25; P=.002); overall complications OR 0.83 (0.64-1.09; P=.19)
BreastQ satisfaction with outcome at median 57-month follow-up: immediate reconstruction plus radiotherapy 71 vs delayed after radiotherapy 85 vs immediate without radiotherapy 81
Integration into clinical practice guidelines and recommendations
Current standard of care and ongoing research directions
Landmark Trials in This Story
Breast reconstruction. Update of psychosocial and pragmatic concerns
Psychosocial and pragmatic concerns
Variation in the provision and practice of implant-based breast reconstruction in the UK: Results from the iBRA national practice questionnaire.
Provision and practice of implant-based reconstruction: 81 units in 79 hospitals (patient outcomes not evaluated)
The effect of immediate breast reconstruction on the timing of adjuvant chemotherapy: a systematic review.
Time to adjuvant chemotherapy: four studies reported delays averaging 6.6-16.8 days after immediate reconstruction; seven reported no significant difference
Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study.
Complications within 3 months: implant loss 9% (95% CI 8-10), readmission 18% (16-20), return to theatre 18% (16-20), treated infection 25% (23-27)
Comparison of Aesthetic Outcomes Between Vertical and Horizontal Flap Insets in Breast Reconstruction with the TRAM or DIEP Flaps.
Aesthetic symmetry and regional volume discrepancy at 6 months (effect estimates not stated in abstract)
Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction: A Systemic Review and Meta-analysis.
Animation deformity: prepectoral vs subpectoral OR 0.02 (95% CI 0.00-0.25; P=.002); overall complications OR 0.83 (0.64-1.09; P=.19)
Multicentre study of patient-reported and clinical outcomes following immediate and delayed Autologous Breast Reconstruction And Radiotherapy (ABRAR study).
BreastQ satisfaction with outcome at median 57-month follow-up: immediate reconstruction plus radiotherapy 71 vs delayed after radiotherapy 85 vs immediate without radiotherapy 81
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.